Sign in

CIK 0001372514

  • Non-accelerated filer
  • Smaller reporting company

KIORA PHARMACEUTICALS INC

Sign in to watch
Tickers
KPRX KPHMW
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
980443284
Phone
+1 858-224-9600
Business address
169 SAXONY RD., SUITE 212, ENCINITAS, CA, 92024
Former names
EYEGATE PHARMACEUTICALS INC

Securities

  • KPRX Common Stock Nasdaq
  • KPHMW Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 73 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2019-08-06 Romano Sarah Chief Financial Officer Shares withheld for taxes −1,649 $0.21 $346 260,464
2019-08-06 MANZO MICHAEL P. VP of Engineering Shares withheld for taxes −1,649 $0.21 $346 173,147
2019-08-06 Mann Brenda VP of Research & Development Shares withheld for taxes −1,641 $0.21 $345 172,783
2019-08-06 Wirostko Barbara Chief Medical Officer Shares withheld for taxes −1,641 $0.21 $345 403,893
2019-07-15 Romano Sarah Chief Financial Officer Sale −6,584 $0.23 $2K 262,113
2019-07-15 MANZO MICHAEL P. VP of Engineering Sale −6,584 $0.23 $2K 174,796
2019-07-15 Wirostko Barbara Chief Medical Officer Sale −6,488 $0.23 $2K 405,534
2019-07-15 FROM STEPHEN President and CEO Sale −42,452 $0.23 $10K 1,032,465
2019-07-15 Mann Brenda VP of Research & Development Sale −6,350 $0.23 $1K 174,424
2019-07-12 Romano Sarah Chief Financial Officer Sale −6,583 $0.24 $2K 268,697
2019-07-12 MANZO MICHAEL P. VP of Engineering Sale −6,583 $0.24 $2K 181,380
2019-07-12 Wirostko Barbara Chief Medical Officer Sale −6,488 $0.24 $2K 412,022
2019-07-12 FROM STEPHEN President and CEO Sale −42,452 $0.24 $10K 1,074,917
2019-07-12 Mann Brenda VP of Research & Development Sale −6,350 $0.24 $1K 180,774
2019-07-11 Romano Sarah Chief Financial Officer Sale −6,583 $0.24 $2K 275,280
2019-07-11 MANZO MICHAEL P. VP of Engineering Sale −6,583 $0.24 $2K 187,963
2019-07-11 Wirostko Barbara Chief Medical Officer Sale −6,487 $0.24 $2K 418,510
2019-07-11 FROM STEPHEN President and CEO Sale −42,451 $0.24 $10K 1,117,369
2019-07-11 Mann Brenda VP of Research & Development Sale −6,349 $0.24 $2K 187,124
2019-03-29 ARMISTICE CAPITAL, LLC Director Purchase +298,189 $0.31 $92K 17,812,500

Page 14 of 24 · 468 trades